OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 289.75

Change

-3.65 (-1.24)%

Market Cap

USD 0.12B

Volume

168.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.55%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.13%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.09%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-0.38 (-0.27%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.07 (-0.13%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.81 (-0.83%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-5.36 (-0.95%)

USD 80.38B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.83% 75% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.83% 75% C 76% C+
Trailing 12 Months  
Capital Gain 17.24% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.24% 58% F 61% D-
Trailing 5 Years  
Capital Gain 38.50% 63% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.50% 63% D 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.68% 59% D- 58% F
Dividend Return 7.68% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.90% 62% D 70% C-
Risk Adjusted Return 77.61% 75% C 78% C+
Market Capitalization 0.12B 35% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.